Ustekinumab Clinical Trials (2026): 176 Studies for Crohn Disease & Psoriasis

Where to Participate: All Ustekinumab Trial Sites in the U.S. (149 sites across 35 states)

Every actively recruiting Ustekinumabtrial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.

Ustekinumab clinical trials at a glance: phase × recruitment status

Recruiting Ustekinumab clinical trials (32)

Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).

Ustekinumab clinical trials by indication

Ustekinumab pivotal trial highlights (Phase 2/3/4)

Phase-2/3/4 studies with named acronyms — the registration-grade trials most cited in label discussions and Wikipedia.

Terminated and withdrawn Ustekinumab trials (20)

Studies that ended before completion. Reasons are filed in each trial's ClinicalTrials.gov entry.

• NCT04060888withdrawnA Study of Ustekinumab in Chinese Participants With Active Systemic Lupus Erythematosus
• NCT04978493terminatedA Study to Test Whether BI 706321 Combined With Ustekinumab Helps People With Crohn's Disease
• NCT04629196terminatedInduction Optimization With Stelara for Crohn's Disease
• NCT03847272terminatedA Multicenter Phase 2 Single-arm Proof-of-concept Trial to Assess the Efficacy and Safety of Ustekinumab in Association With Prednisone for the Treatment of Non-infectious Severe Uveitis (NISU)
• NCT04655807withdrawnA Study of JNJ-64304500 as Add-on Therapy in Participants With Active Crohn's Disease
• NCT04882072terminatedA Study of Ustekinumab in Participants With Takayasu Arteritis (TAK)
• NCT04305327terminatedEfficacy and Safety of Brodalumab in Adolescents From 12 to 17 Years of Age With Moderate-to-severe Plaque Psoriasis
• NCT03712826withdrawnIdentification by Cytometry by Mass of Predictive Immunological Profiles of Answer to Treatmentby Biotherapics for Patients With Crohn's Disease
• NCT03981744terminatedA Study of Ustekinumab in Participants With Active Polymyositis and Dermatomyositis Who Have Not Adequately Responded to One or More Standard-of-care Treatments
• NCT03358706terminatedA Study to Evaluate the Effect of Ustekinumab on Cytochrome P450 Enzyme Activities Following Induction and Maintenance Dosing in Participants With Active Crohn's Disease or Ulcerative Colitis
• NCT03517722terminatedA Study of Ustekinumab in Participants With Active Systemic Lupus Erythematosus
• NCT02955147terminatedUstekinumab for the Treatment of Giant Cell Arteritis
• NCT02786732terminatedStudy to Evaluate Broadlumab vs Placebo and Ustekinumab
• NCT02407223terminatedAn Efficacy and Safety Study of Ustekinumab in Participants With Active Nonradiographic Axial Spondyloarthritis
• NCT02437162terminatedA Study to Evaluate the Efficacy and Safety of Ustekinumab in the Treatment of Anti-TNFα Naive Participants With Active Radiographic Axial Spondyloarthritis
• NCT02438787terminatedA Study to Evaluate the Efficacy and Safety of Ustekinumab in the Treatment of Anti-TNF(Alpha) Refractory Participants With Active Radiographic Axial Spondyloarthritis
• NCT01708629terminatedEfficacy and Safety of Brodalumab Compared With Placebo and Ustekinumab in Moderate to Severe Plaque Psoriasis Subjects
• NCT01708603terminatedP3 Study Brodalumab in Treatment of Moderate to Severe Plaque Psoriasis
• NCT01647152withdrawnUstekinumab for Active Sight-Threatening Uveitis
• NCT01091051terminatedSafety and Efficacy of Ustekinumab in Patients With Palmo-Plantar Pustular Psoriasis or With Palmo-Plantar Pustulosis

All Ustekinumab trials (176)

Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.

Ustekinumab clinical trials: frequently asked questions

How many Ustekinumab clinical trials are there?

176 Ustekinumab clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 21 are actively recruiting participants. 100 are marked completed.

Are Ustekinumab clinical trials recruiting in 2026?

Yes — 21 Ustekinumab trials are actively recruiting in 2026, with 149 U.S. sites across 35 states. See the recruiting trials and the per-state site list further down this page.

What conditions is Ustekinumab being studied for?

Ustekinumab is being studied for Crohn Disease, Psoriasis, Crohn's Disease, Ulcerative Colitis, Plaque Psoriasis and 84 more. The trials are grouped by indication on this page.

What phase is Ustekinumab in?

Ustekinumab clinical trials span 21 Phase 4, 58 Phase 3, 31 Phase 2, 13 Phase 1. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.

Who sponsors Ustekinumab clinical trials?

The lead sponsor across the most Ustekinumab trials is Janssen Research & Development, LLC, with 89 additional lead sponsors listed in the data. Each trial row links to the full study detail page including sponsor information.

Sources and methodology

Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming Ustekinumabas an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.

Last refreshed June 18, 2026.